Wordt geladen...
Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis
CD4(+)CD25(+) regulatory T cells (T reg cells) play a key role in controlling autoimmunity and inflammation. Therefore, therapeutic agents that are capable of elevating numbers or increasing effector functions of this T cell subset are highly desirable. In a previous report we showed that a superago...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The Rockefeller University Press
2005
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2213080/ https://ncbi.nlm.nih.gov/pubmed/16061730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20051060 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|